involved in the pathogenesis of UVB-induced skin cancer.
Production of reactive oxygen species (ROS) by iron can
Promotion of UVB-induced epidermal tumors occurs over contribute directly to DNA and protein damage and may a long period of time, via outgrowth of initiated cells. UVB contribute to cell signaling and proliferation. We have light can cause growth-stimulatory effects via induction of cell examined the effects of the iron(III) chelator deferroxamine signaling pathways, or secondary to inflammation. UVB causes (DFO) and iron (FeCl 3 ) on UVB (290-320 nm)-induced activation of both the NFκB and activator protein 1 (AP-1) activator protein 1 (AP-1) signaling. The ability of DFO to transcription factor complexes (29-33), and antioxidants inhibit inhibit UVB-induced AP-1 transactivation was tested in a UVB-induced AP-1 expression (34) . AP-1 is a transcription human keratinocyte cell line stably transfected with a factor complex that is involved in the activation of multiple luciferase reporter driven by a single AP-1 element. DFO genes by UVB (the 'UV response'). The transient induction treatment 24 h prior to UVB irradiation reduced UVBof AP-1 has been shown to be involved in the promotion of induced AP-1 transactivation by~80%, with the effect of epidermal tumors, and AP-1 activity has been implicated in DFO diminishing as pre-treatment time was shortened.
neoplastic transformation in vitro and in epidermal tumors Treatment with FeCl 3 a minimum of 6 h prior to UVB (35) (36) (37) (38) (39) . Constitutive AP-1 activity has been associated with potentiated the UVB induction of AP-1 transactivation by the malignant conversion of papillomas to carcinomas (40) as 2-3-fold. DFO was able to ablate both the UVB induction well. Chemopreventive agents or modifications of AP-1 proof AP-1 transactivation as well as the potentiation by FeCl 3 .
teins that inhibit AP-1 activation are effective in preventing The antioxidants Trolox and N-acetyl cysteine were both cell transformation or tumorigenesis due to chemicals or able to inhibit UVB-induced AP-1 transactivation and UV light (30, 36, 37, 41, 42) . Inhibition of UVB-induced AP-1 Trolox was able to inhibit the potentiation of UVB-induced signaling by antioxidants or by iron chelators would lend AP-1 by FeCl 3 . These results indicate that UVB-induced validity to the idea that UVB-and iron-induced ROS are AP-1 activation may be in part due to oxidant effects of important in UVB-induced cell signaling. UVB and intercellular iron.
Deferoxamine (DFO) is an iron chelator that has long been used in patients with acute iron poisoning (43) and iron overload resulting from multiple transfusions in patients with Introduction β-thallassaemia major, or in patients with primary hemoDiseases of iron overload result in significant tissue damage chromatosis (44) (45) (46) (47) . More recently, DFO has been tested in to the liver and other organs if not managed with iron chelators animal models of diseases known to be influenced by oxidative (1) . Elevated body iron is also associated with an increased damage, such as cardiovascular disease, neurodegenerative risk of cancer in humans, and in rodents iron overload has disease, hepatocarcinogenesis and ischemia-reperfusion injury been shown to enhance colon and mammary carcinogenesis (48) (49) (50) (51) (52) . DFO has been shown to inhibit phorbol ester-induced (2-12). The ability of iron to generate reactive oxygen species hyperplasia in mouse ear skin (53), UVB-induced oxidative (ROS) via the Fenton reaction and cause oxidative damage is stress in corneal epithelial cells and murine fibroblasts (54,55) thought to be one of the primary mechanisms of iron-induced and the formation of an oxidative DNA lesion, 8-OHdG in tissue damage (13-15). Oxidative stress is thought to cause neutrophils (56) , suggesting inhibition of oxidative damage, release of iron from its storage proteins as well, leading to presumably via iron chelation and inhibition of iron-induced further oxidative damage (12,16,17). Many diseases are initiFenton chemistry. DFO itself is a reductant, and may affect ated or exacerbated by oxidative damage, and may thus be the redox status of the cell in that manner as well. In sensitive to changes in iron in the cell. Inhibition of UVBhuman dermal fibroblasts DFO inhibits UVB-induced lipid induced tumors in mice with antioxidant treatments (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) peroxidation, UVB-induced collagenase and c-jun mRNA suggests the importance of oxidative damage in the induction levels and UVB-induced JNK2 activity (57), suggesting a of skin cancer by UVB. Oxidative damage to lipids, proteins potential role for iron in UVB-induced cell signaling, which and DNA by UVB have all been implicated in skin tumor may be linked to the formation of ROS in the cell. We have hypothesized that sustained induction of the tran- the hypothesis that inhibition of UVB-induced AP-1 will contribute to chemoprevention of NMSC. We have examined the effects of UVB, iron, an iron chelator and antioxidants on AP-1 transactivation in a human keratinocyte cell line (HaCaT). UVB-induced ROS may be involved in induction of AP-1 transactivation in human keratinocytes, and iron-driven generation of ROS may increase UVB-induced AP-1 transactivation. . Approximately 80% of the lamp output was in the UVB spectrum (290-320), Ͻ1% in the UVC spectrum (Ͻ290 nm), 4% in the UVA spectrum (320-400 nm), and the remainder was in the visible spectrum according to manufacturer's specifications. Other reagents were obtained commercially from standard sources and used without purification. we postulated that ROS may be affecting the AP-1 signaling pathway. Cells were then treated with antioxidants to determine their effects on UVB-or iron-induced AP-1 activity. Antioxidants inhibit UVB-and FeCl 3 -induced AP-1 NAC, a thiol reductant, antioxidant and glutathione precursor, and Trolox, a water-soluble vitamin E derivative, were both effective in inhibiting UVB-induced AP-1 transactivation, and Trolox was effective in inhibiting the potentiation of UVBinduced AP-1 by FeCl 3 (Figures 4 and 5) . In Figure 4 , cells were treated with NAC immediately following UVB, and NAC containing media was removed from the cells 6 h after UVB, NAC treatment was ineffective in inhibiting UVBinduced AP-1 activity (Figure 4B ), suggesting that early oxidative events are important in the induction of AP-1 AP-1 activity was not affected by iron in unirradiated cells (data not shown). A minimum of 6 h of FeCl 3 treatment prior transactivation. We attempted to ascertain the effect of NAC on the potentiation of UVB-induced AP-1 by iron as well. to UVB was necessary to cause a significant increase in UVBinduced AP-1 ( Figure 2B ), suggesting that the cells capacity However, the combination of iron and NAC was toxic to the cells, and no reliable estimate of AP-1 activity could be to store free iron has been exceeded by this extended iron treatment.
Materials and methods

Chemicals
ascertained (data not shown). In Figure 5A , Trolox was added to the cells 24 h prior to UVB treatment, and Trolox treatment DFO (0.4 mM) was able to inhibit both UVB-induced AP-1 and the potentiation of UVB-induced AP-1 by FeCl 3 (0.6 mM) was continued following UVB irradiation. Shorter Trolox treatment times prior to UVB treatment were ineffective in (Figure 3) , suggesting that the iron-chelating properties of DFO account for the inhibition of UVB-induced AP-1, and inhibiting UVB-induced AP-1 (data not shown). Treatments of 1 and 3 mM Trolox inhibited UVB-induced AP-1 transactivnot a non-specific effect of DFO on cell signaling. Due to the fact that both UVB and iron induce an oxidative insult in cells ation by~30 and 75% respectively. A complication introduced into the experiment by adding Trolox to the cells prior to UVB and the fact that UVB treatment can release FeCl 3 from ferritin in the cell, causing further oxidative insult via Fenton chemistry, involves the UVB-absorbing characteristics of Trolox. One cell may cause lipid, protein and DNA damage, and proliferation via cell signaling pathways. Much is known about the effects of UVC-induced ROS on cell signaling pathways in a variety of cell types but, in contrast, very little is known about cell signaling pathways affected by the more biologically relevant UVB.
In the present study, we have demonstrated the ability of the iron chelator DFO and the antioxidants Trolox and NAC to inhibit UVB-induced AP-1 signaling. In addition, the contribution of free cellular iron to UVB-induced AP-1 signaling has been shown. These observations suggest a role for iron chelation in the prevention of tumor promotion by UVBinduced oxidants. The majority of iron in the cell is tightly bound to ferritin, the major iron-storage protein in the cell. Iron is also associated with other low affinity ligands such as proteins, ATP and cellular lipids (58-62). This loosely bound iron and a cellular fraction of 'free iron' also known as the labile iron pool, or LIP, is available for oxidative chemistry via the Fenton reaction. Free iron levels are closely regulated by ferritin synthesis and binding. If there is an increase in iron or oxidative damage in the cell, iron regulatory proteins initiate the synthesis of ferritin in the cell, to decrease levels of free iron (14,63). In the presence of UVB-induced oxidants, a transient increase in free iron can occur via release of iron from ferritin (12,17,64). The changes in cellular iron localization in the presence of UVB light suggests a role for iron in the exacerbation of ROS formation by UVB, which can contribute that indeed 'free iron' is increased with UVB treatment, and the ROS cycle established with UVB and iron may contribute cannot distinguish between sunscreening versus antioxidant to the UVB-induced AP-1 signaling in the cell. If this is true, effects of Trolox on UVB-induced AP-1 if Trolox is added to then additional increases in free iron should further increase the cells before UVB irradiation. To address this point, cells UVB-induced AP-1. We have modeled a significant increase were also treated with a Trolox derivative, containing a methyl of 'free iron' in the cell via the addition of exogenous iron in ether at the 6-OH position of the Trolox chromanol ring.
the form of FeCl 3 . FeCl 3 causes a potentiation of UVB-induced This non-hydrolyzable modification blocks the antioxidant AP-1 signaling in HCL14 cells, and DFO is able to inhibit the capabilities of the chromanol hydroxyl group, but maintains effects of exogenously added iron on UVB-induced AP-1 the UVB-absorbing characteristics of Trolox. Trolox-Me did signaling. DFO is loaded into the cell prior to the exposure of not significantly inhibit UVB-induced AP-1 at 1 and 3 mM the cells to exogenous iron; therefore, the effect of DFO is doses ( Figure 5B) , suggesting that the actions of Trolox on not to inhibit the entrance of iron into the cell, it is to chelate UVB-induced AP-1 are due primarily to its antioxidant actions the free iron in the cell. The fact that a 6 h treatment with rather than its sunscreening actions. Trolox also inhibits the iron is necessary to elicit a potentiating response on AP-1 potentiation of UVB-induced AP-1 by FeCl 3 ( Figure 5C ), signaling suggests that the cellular capacity of ferritin for the suggesting that iron induction of UVB-induced AP-1 is incoming iron has been exceeded, and ferritin is not being dependent on the generation of ROS by iron.
synthesized fast enough to bind the incoming iron. Interestingly, iron treatment alone is not sufficient to increase AP-1 signaling Discussion in the cell. There is no increase in basal AP-1 signaling in control unirradiated cells treated with iron. The combination NMSC, which includes both basal and squamous cell carcinomas, is a very common malignancy in modern sunbathof UVB and free iron is necessary to initiate the cycle of Fenton chemistry. UVB causes increases in lipid peroxide, ing societies. Many recent chemopreventive strategies for NMSC have centered on prevention of UVB-induced skin superoxide and other oxidants in the cell which can lead to oxidative damage if they are not first scavenged by cellular damage and tumorigenesis, with the inhibition of UVB-induced oxidative damage at the forefront. UVB-induced ROS in the antioxidants. Hydrogen peroxide is produced secondary to have an effect on UVB-induced ROS. Trolox is also able to tea, green tea, decaffeinated black tea and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]-anthracene-initiated SKH-1 mice. Cancer Res., 54, 3428-3435.
